Australia: Health Alert : 20 February 2012

Last Updated: 22 February 2012
Article by Michael Regos


Australia. High Court

Patel v The Queet [2012] HCATrans 19 (10 February 2012)

This is a transcript from an application by Jayant Patel in the High Court of Australia seeking special leave to appeal a decision of the Queensland Court of Appeal. Mr Patel was convicted on three counts of manslaughter and one of unlawful grievous bodily harm for deciding to operate on a patient whose health was precarious. The patient suffered bleeding that could not be stopped and later died.

Counsel for Mr Patel argued that he did not have a trial according to law because he had been tried under section 288 of the Criminal Code (Qld), which does not include the decision to operate, and he should have been tried under section 282, which does.

Counsel submitted that the trial was a miscarriage of justice because the law was incorrectly put before the jury, and because the jury had heard much prejudicial evidence regarding the surgery, when the competence of the surgery was no longer an issue.

The Crown argued that the words in section 288 should capture the decision to operate, and the concept of surgery is wide and includes the decision. The Crown also argued that the evidence regarding surgery was necessary and relevant to prove causation.

The Court granted the application for leave to appeal based on the interpretation of the Criminal Code (Qld). The Court requested further particulars regarding the miscarriage of justice and referred the application to an expanded court.

Australia. Federal Court

Secretary, Department of Health and Ageing v Export Corporation (Australia) Pty Ltd [2012] FCA 42 (3 February 2012)

The Secretary of the Department of Health and Ageing brought an application in the Federal Court before Perram J against Export Corporation (Australia) Pty Ltd (respondent) for importing and supplying therapeutic goods in contravention with the Therapeutic Goods Act 1989 (Cth) (Act).

The Act proscribes the importation or supply of therapeutic goods that are neither listed nor registered with the Australian Register of Therapeutic Goods (ARTG). Goods that contain certain harmful ingredients cannot be listed and must be registered. A number of the products imported and supplied by the respondent contained such ingredients, and were not registered.

The facts were not contested, so the court assessed the appropriate size of the civil penalty. Perram J held that there were 10 contraventions, each with a maximum penalty of $5.5 million. His Honour considered that the respondent had not previously contravened the Act, the contravention was not deliberate (based on a reasonable misunderstanding), no loss was suffered by anyone as a consequence and also that the error was made at a high level in ignorance of the seriousness of the requirements.

The court stated that the purpose of the penalty was punishment and deterrence, both of the wrongdoer and others, and decided the total penalty was $4.811 million. This was reduced to $3.127 million due to the respondent's cooperation with the Secretary. The court ordered the parties to bring in short minutes of order within seven days giving effect to the reasons.

New South Wales. Psychologists Tribunal

HCCC v Whyte (No 2) [2012] NSWPST 4 (16 February 2012) LEGISLATION Commonwealth



Private Health Insurance (Prostheses) Rules 2012 (No. 1) F2012L00335 o as made

National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2012 (No. 1) (No. PB 1 of 2012) F2012L00288 o PB 1 of 2012 as made

National Health (Price and Special Patient Contribution) Amendment Determination 2012 (No. 1) (No. PB 2 of 2012) - F2012L00272 o PB 2 of 2012 as made


Australia. Department of Health & Ageing

Media releases

Private Health Insurance Circular - PHI 08/12 Delay of the February 2012 Prostheses List

Australia. Parliamentary Library

Private health insurance premium increases - an overview and update [ PDF 486KB]

Australia. Private Health Insurance Administration Council

16 February 2012 - Notification Requirements Under The Private Health Insurance (Insurer Obligations) Rules 2009 - Current Edition - 12/03

Australia. Medical Board of Australia

8 February 2012 - The Medical Board of Australia has released a consultation paper on the funding of external doctors' health programs. | Read Article

Australia. Nursing & Midwifery Board of Australia

1 February 20120 - The Nursing and Midwifery Board of Australia releases its latest communique. | Read Article

Australia. Podiatry Board of Australia

9 February 2012 - The Podiatry Board of Australia releases a consultation paper on Specialist Registration Standards. | Read Article

7 February 2012 - The Podiatry Board of Australia releases its latest communique. | Read Article

Australia. Chinese Medicine Board of Australia

14 February 2012 - Interview with Professor Charlie Xue, Chair of the Chinese Medicine Board of Australia discussing registration. | Read Article

14 February 2012 - The Board has released further answers to frequently asked questions regarding its English Language Standard. | Read Article

Australian Institute of Health & Welfare

15 February 2012 - Incidence of insulin-treated diabetes in Australia 2000-2009 (media release)

10 February 2012 - Comorbidity of mental disorders and physical conditions 2007

Australia. National Health & Medical Research Council

9 February 2012 - 10 of the Best Health and Medical Research Projects 2011 Launch - Cone snails are not an obvious place to look for medicine's next significant breakthrough, but this is exactly where Dr Richard Lewis and his research team have found a promising new treatment for chronic pain. This research, which is currently at the clinical trial stage, makes use of cone snail toxins to create new pain treatments that lack the side effects associated with existing drugs. It is one of the research projects showcased in the National Health and Medical Research Council...

Australia. Therapeutic Goods Administration

16 February 2012 - Documents released under Section 11C of the Freedom of Information Act 1982. Added FOI 219-1112 documents.

16 February 2012 - Greenridge herbal liquid medicines: swapped labels - This recall is being conducted because the affected bottles have been mislabelled.

13 February 2012 - Advisory Committee on the Safety of Medicines (ACSOM) - Updated membership information.

10 February 2012 - Poly Implant Prothese (PIP) breast implants - TGA update - Updated information on PIP breast implants.

10 February 2012 - Export Corporation penalised $3.1 million for importing and supplying products not on the ARTG - On 3 February 2012 the Federal Court ruled that Export Corporation (Australia) Pty Ltd should pay civil penalties of just over $3.1 million for importing and supplying a number of products that were not on the ARTG.

New South Wales. Ministry of Health

Media releases

Queensland. Department of Health

Media releases

South Australia. Department of Health

Media releases

Tasmania. Department of Health & Human Services

Media releases

Victoria. Department of Health

Media releases

Western Australia. Department of Health

Media releases

New Zealand. Ministry of Health

13 February 2012 - Mental Health and Addiction: Service use 2009/10 (provisional) - This publication provides information on mental health and addiction services provided by secondary organisations in the 2009/10 financial year (July 009 to June 2010).

United Kingdom. Department of Health

NPC publishes reports into controlled drugs - The National Prescribing Centre (NPC) has published three reports commissioned by the Department of Health, concerning the safe management and use of controlled drugs in the ambulance and paramedic sector.

Health and Social Care Bill explained - The Health and Social Care Bill is now in its Report Stage in the House of Lords.

Online patient feedback linked to hospital performance - Imperial College London has published independent research that links online patient feedback and objective measures of hospital performance.

National Institute for Health Research to award professorships - Eight of the UK's most promising leaders in medical health research will each be awarded a National Institute for Health Research professorship, the Government announced today.

Ten reasons why we need a Bill to make these reforms work - Health Minister Simon Burns explains why the Health and Social Care Bill is needed to make the changes that are being proposed for the NHS.

Responsibility deal showcases collaborative work to improve public health - If you're interested in finding out more about how to get involved in improving public health - as an employer, or through commercial actions or community activities.

Smokers are urged to quit for Valentine's Day - Smokers are being urged to improve their romantic chances by stopping smoking on Valentine's Day. They can pick up a free Quit Kit from their local pharmacy.

Australian Medical Association

13 February 2012 - Savings from private health means test changes must go to health - AMA President, Dr Steve Hambleton said today that,should the Government succeed in getting its private health insurance means test changes through the Parliament, all savings should be ploughed back into the health system. Dr Hambleton said that the extra funding would assist cover existing need in the system and help compensate the public hospital system for any extra demand that may occur as a result of the changes.

© DLA Piper

This publication is intended as a general overview and discussion of the subjects dealt with. It is not intended to be, and should not used as, a substitute for taking legal advice in any specific situation. DLA Piper Australia will accept no responsibility for any actions taken or not taken on the basis of this publication.

DLA Piper Australia is part of DLA Piper, a global law firm, operating through various separate and distinct legal entities. For further information, please refer to

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Mondaq Advice Centre (MACs)
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.